Immunohistochemical results from HPA database showed that the expression of TFAP2A, TFAP2B and TFAP2C in clinical samples of bladder cancer patients was higher than that in normal tissues (Figure 2). This evidence concerns the gene TFAP2B and urinary bladder cancer.